May 28, 2026
In the News
Press Releases and Media Coverage
April 16, 2026
PHST001 combination with standard-of-care chemotherapy enhances macrophage-mediated elimination of tumor cells
April 16, 2026
Initial results from a Phase 1 study of PHST001, a macrophage activating anti-CD24 antibody, in patients with advanced/metastatic solid tumors
April 16, 2026
PHST001, a humanized anti-CD24 hIgG4 antibody, is effective against metastatic tumors and retains its anti-tumor activity in the presence of competing IgG
December 9, 2025
PHST001, a humanized anti-CD24 antibody, induces phagocytosis of human tumor cells in vitro and tumor clearance in vivo.
December 9, 2025